Context Therapeutics (CNTX) Research & Development (2020 - 2026)
Context Therapeutics (CNTX) recorded Research & Development of $5.72 million in Q3 2026, down 34.5% from $8.72 million a year earlier and down 54.4% from the prior quarter.
Context Therapeutics (CNTX) Research & Development (2020 - 2026) Analysis & Trends
On a TTM basis, Context Therapeutics' Research & Development came in at $37.1 million as of Sep 30, 2026, up 64.7% year-over-year; for FY2025, it was $31.86 million, up 40.3% from FY2024.
- Annual Research & Development has increased for five straight years, with a five-year compound annual growth rate of 81.0% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $22.7 million in FY2024 (+27.7%), $17.78 million in FY2023 (+150.8%), $7.09 million in FY2022 (+86.4%) and $3.81 million in FY2021 (+131.8%).
- The Q3 2026 figure is the lowest quarterly Research & Development since Q1 2025.
- On a year-over-year basis, Research & Development rose in five of the last eight quarters, with growth averaging 117.3%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 465.6% in Q2 2025, against a decline of 60.0% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $12.53 million (Q2 2026), $7.02 million (Q1 2026) and $11.84 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | 322,296.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 4.25 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 4.65 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 2.57 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 4.54 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Context Therapeutics | 15.24 Mn | -182.70 Mn | - | 5.72 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.72 Mn |
| Jun 30, 2026 | 12.53 Mn |
| Mar 31, 2026 | 7.02 Mn |
| Dec 31, 2025 | 11.84 Mn |
| Sep 30, 2025 | 8.72 Mn |
| Jun 30, 2025 | 7.83 Mn |
| Mar 31, 2025 | 3.46 Mn |
| Dec 31, 2024 | 2.52 Mn |
| Sep 30, 2024 | 16.83 Mn |
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 1.97 Mn |
| Dec 31, 2023 | 5.30 Mn |
| Sep 30, 2023 | 4.49 Mn |
| Jun 30, 2023 | 3.46 Mn |
| Mar 31, 2023 | 4.53 Mn |
| Dec 31, 2022 | 2.14 Mn |
| Sep 30, 2022 | 2.08 Mn |
| Jun 30, 2022 | 1.52 Mn |
| Mar 31, 2022 | 1.35 Mn |
| Dec 31, 2021 | 1.29 Mn |
Context Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CNTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();